Inhaled dual bronchodilator therapy did not decrease respiratory symptoms among individuals who were current or former smokers and had respiratory symptoms but preserved lung function without COPD, ...

Individuals with pre-bronchodilator airflow obstruction appeared to be at significant risk for future COPD development, researchers reported in the American Journal of Respiratory and Critical Care ...

Among 535 symptomatic smokers with a 10 pack-year history and preserved lung function assessed by spirometry, 56.4% in the treatment group and 59.0% in the placebo group had a least a 4-point decrease ...

Pulmonary diagnostic tests are a series of tests which evaluate how well the lungs are performing. These tests may be performed to help diagnose disease, monitor disease progression or therapeutic ...

A diagnosis of COPD is confirmed by post‑bronchodilator spirometry supported by a quality-control process. To ensure early diagnosis, spirometry should be done in primary care when a person presents ...

Eighteen RCTs with a total of 6086 patients were included in the analysis. For patients with moderate to severe chronic obstructive pulmonary disease (COPD), dual bronchodilator therapy with a ...

A bronchodilator is a medication that relaxes and opens the airways, or bronchi, in the lungs. A doctor may prescribe them for asthma and other respiratory conditions. Narrowed airways make it ...

COPD can be managed with medications like bronchodilators and corticosteroids, which reduce airway inflammation and open airways for easier breathing. Vaccines for the flu, pneumonia, shingles, RSV, ...